Get the Stockscreener App
8.15
0.74%
0.06
After Hours:
8.02
-0.13
-1.60%
Ginkgo Bioworks Holdings Inc stock is traded at $8.15, with a volume of 808.53K.
It is up +0.74% in the last 24 hours and up +21.82% over the past month.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.
See More
Previous Close:
$8.09
Open:
$8.01
24h Volume:
808.53K
Relative Volume:
0.50
Market Cap:
$449.60M
Revenue:
$251.46M
Net Income/Loss:
$-892.87M
P/E Ratio:
-11.48
EPS:
-0.71
Net Cash Flow:
$-336.30M
1W Performance:
+4.09%
1M Performance:
+21.82%
6M Performance:
-82.44%
1Y Performance:
-88.74%
1-Day Range:
$7.91
$8.40
1-Week Range:
$7.42
$8.42
52-Week Range:
$5.26
$75.20
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Name
Ginkgo Bioworks Holdings Inc
Sector
Industry
Phone
(877) 442-5362
Address
27 DRYDOCK AVENUE, BOSTON
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-09-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-02-23 | Downgrade | Goldman | Neutral → Sell |
| May-11-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-29-22 | Initiated | Berenberg | Buy |
| Oct-04-22 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Feb-23-22 | Initiated | Goldman | Neutral |
| Feb-01-22 | Initiated | BofA Securities | Neutral |
| Jan-28-22 | Initiated | BofA Securities | Buy |
| Jan-07-22 | Initiated | BTIG Research | Buy |
| Nov-29-21 | Initiated | Jefferies | Buy |
| Oct-13-21 | Initiated | Raymond James | Outperform |
| Oct-12-21 | Initiated | William Blair | Outperform |
| Sep-20-21 | Initiated | HSBC Securities | Buy |
View All
Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News
122,718 Shares in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Bought by Wellington Wealth Strategies LLC. - MarketBeat
After Plunging -40.22% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) - MSN
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? - MSN
Benjamin F. Edwards & Company Inc. Raises Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
933,898 Shares in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Purchased by XTX Topco Ltd - MarketBeat
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
(DNA) Trading Advice - Stock Traders Daily
Novus, Ginkgo Bioworks partner to develop new feed additives - FeedStrategy.com
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture - StockTitan
What's Going On With Ginkgo Bioworks Stock This Week? - MSN
Ginkgo Bioworks (NYSE:DNA) PT Raised to $10.00 at TD Cowen - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Down 6.4% - MarketBeat
Ginkgo Bioworks stock target raised, keeps buy rating on new data portfolio - Investing.com
Ginkgo Bioworks stock target raised, keeps buy rating on new data portfolio - Investing.com Australia
Ginkgo Bioworks stock target raised, keeps buy rating on new data portfolio - Investing.com Canada
Ginkgo Bioworks stock target raised, keeps buy rating on new data portfolio - Investing.com UK
Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement - Longview News-Journal
210,000 Shares in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Purchased by Thoroughbred Financial Services LLC - MarketBeat
Sargent Investment Group LLC Has $37,000 Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
What's Going On With Ginkgo Bioworks Stock This Week? - Benzinga
Pomerantz LLP Announces that this is a Reminder of a Proposed Class Action Settlement on Behalf of Purchasers of Ginkgo Bioworks Holdings, Inc. Common Stock - GlobeNewswire Inc.
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology - PR Newswire
Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today - sharewise
Ginkgo Bioworks Holdings (NYSE:DNA) Stock Quotes, Forecast and News Summary - Benzinga
Ginkgo Bioworks stock retains buy rating, $3.00 target amid AI growth - Investing.com
Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today - Yahoo Finance
Ginkgo Bioworks stock retains buy rating, $3.00 target amid AI growth - Investing.com India
Ginkgo Bioworks (NYSE:DNA) Stock Price Up 8.3% - MarketBeat
TD Cowen Reiterates Buy Rating on Ginkgo Bioworks Holdings Inc (DNA) - StreetInsider.com
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development - Benzinga
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why - Benzinga
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology - Kilgore News Herald
Ginkgo Bioworks (NYSE:DNA) Sees Unusually-High Trading Volume - MarketBeat
Ginkgo and Google Cloud Team Up to Supercharge Drug Development with New Protein LLM - SynBioBeta
Ginkgo Bioworks executive sells over $7,000 in stock By Investing.com - Investing.com Australia
Ginkgo Bioworks executive sells over $7,000 in stock By Investing.com - Investing.com Canada
Ginkgo Bioworks executive sells over $1,900 in stock - Investing.com India
Ginkgo Bioworks executive sells over $7,000 in stock - Investing.com
Ginkgo Bioworks executive sells over $1,900 in stock By Investing.com - Investing.com UK
Ginkgo Bioworks executive sells over $7,000 in stock By Investing.com - Investing.com UK
When the Price of (DNA) Talks, People Listen - Stock Traders Daily
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Short Interest Up 86.2% in August - MarketBeat
Is Ginkgo Bioworks Holdings, Inc. (DNA) A Good High Risk High Reward Growth Stock To Buy? - Insider Monkey
Is Ginkgo Bioworks Holdings, Inc. (DNA) A Good High Risk High Reward Growth Stock To Buy? - Yahoo Finance
Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement - Kilgore News Herald
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Position Reduced by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference - Kilgore News Herald
Monaco Asset Management SAM Acquires New Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
10 High Risk High Reward Growth Stocks Stocks To Buy - Insider Monkey
Ginkgo Bioworks Holdings Inc Stock (DNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):